Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C LeRoy

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Clinical and Experimental Rheumatology|September 11, 1992
Raynaud's phenomenon: a proposal for classificationE C LeRoy, T A Medsger
American Heart Journal|November 1, 1981
Primary heart disease in systemic sclerosis (scleroderma): advances in clinical and pathologic features, pathogenesis, and new therapeutic approachesG R Botstein, E C LeRoy
Journal of the South Carolina Medical Association (1975)|November 1, 1993
Lupus and its managementD M Fagundus, E C Leroy
Journal of the South Carolina Medical Association (1975)|November 1, 1993
Raynaud's phenomenon and connective tissue diseasesP A Waller, E C Leroy
Microvascular Research|July 1, 1976
Human alveolar basement membrane. Chemical and immunologic comparisons with glomerular basement membrane and trophoblast basement membraneB A Bray, E C LeRoy
Clinics in Dermatology|July 1, 1994
Cytokines and systemic sclerosisD M Fagundus, E C Leroy
Comprehensive Therapy|February 1, 1981
Raynaud's phenomenon and sclerodermaF E Harper, E C LeRoy
Clinical and Experimental Rheumatology|July 1, 1990
The changing face of severe scleroderma in five patientsM S Spooner, E C LeRoy
Bulletin on the Rheumatic Diseases|October 1, 1996
Paul Klee and sclerodermaE C LeRoy, R M Silver
Annals of the Rheumatic Diseases|July 16, 2002
A profibrotic polymorphism (of TGFbeta1) in systemic sclerosisJ P Pandey, E C LeRoy
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Rheumatology|September 11, 1992
Raynaud's phenomenon: a proposal for classificationE C LeRoy, T A Medsger
American Heart Journal|November 1, 1981
Primary heart disease in systemic sclerosis (scleroderma): advances in clinical and pathologic features, pathogenesis, and new therapeutic approachesG R Botstein, E C LeRoy
Journal of the South Carolina Medical Association (1975)|November 1, 1993
Lupus and its managementD M Fagundus, E C Leroy
Journal of the South Carolina Medical Association (1975)|November 1, 1993
Raynaud's phenomenon and connective tissue diseasesP A Waller, E C Leroy
Microvascular Research|July 1, 1976
Human alveolar basement membrane. Chemical and immunologic comparisons with glomerular basement membrane and trophoblast basement membraneB A Bray, E C LeRoy
Clinics in Dermatology|July 1, 1994
Cytokines and systemic sclerosisD M Fagundus, E C Leroy
Comprehensive Therapy|February 1, 1981
Raynaud's phenomenon and sclerodermaF E Harper, E C LeRoy
Clinical and Experimental Rheumatology|July 1, 1990
The changing face of severe scleroderma in five patientsM S Spooner, E C LeRoy
Bulletin on the Rheumatic Diseases|October 1, 1996
Paul Klee and sclerodermaE C LeRoy, R M Silver
Annals of the Rheumatic Diseases|July 16, 2002
A profibrotic polymorphism (of TGFbeta1) in systemic sclerosisJ P Pandey, E C LeRoy
Pageof 18